BR112014017260A2 - formas e sais de um inibidor de di-hidropirrolo[1,2-c]imidazolil aldosterona sintase ou aromatase - Google Patents

formas e sais de um inibidor de di-hidropirrolo[1,2-c]imidazolil aldosterona sintase ou aromatase

Info

Publication number
BR112014017260A2
BR112014017260A2 BR112014017260A BR112014017260A BR112014017260A2 BR 112014017260 A2 BR112014017260 A2 BR 112014017260A2 BR 112014017260 A BR112014017260 A BR 112014017260A BR 112014017260 A BR112014017260 A BR 112014017260A BR 112014017260 A2 BR112014017260 A2 BR 112014017260A2
Authority
BR
Brazil
Prior art keywords
salts
forms
aldosterone synthase
dihydropyrrolo
imidazolyl
Prior art date
Application number
BR112014017260A
Other languages
English (en)
Other versions
BR112014017260A8 (pt
Inventor
Loeser Eric
Sutton Paul
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=47604250&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BR112014017260(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of BR112014017260A2 publication Critical patent/BR112014017260A2/pt
Publication of BR112014017260A8 publication Critical patent/BR112014017260A8/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/12Drugs for disorders of the urinary system of the kidneys
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/38Drugs for disorders of the endocrine system of the suprarenal hormones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/38Drugs for disorders of the endocrine system of the suprarenal hormones
    • A61P5/46Drugs for disorders of the endocrine system of the suprarenal hormones for decreasing, blocking or antagonising the activity of glucocorticosteroids

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

resumo patente de invenção: "formas e sais de um inibidor de di-hidropirrolo[1,2-c]imidazolil aldosterona sintase ou aromatase". a invenção refere-se a um sal de fosfato ou um sal de nitrato de 4-(r)-6,7-di-hidro-5h-pirrolo[1,2-c]imidazol-5-il-3-fluoro-benzonitrila, especialmente em forma cristalina, e formas específicas destes sais, bem como modalidades da invenção relacionadas. os sais e formas de sais permitem o tratamento profilático e/ou terapêutico de doenças ou distúrbios mediados por aldosterona sintase e/ou aromatase. 21780622v1
BR112014017260A 2012-01-17 2013-01-15 formas e sais de um inibidor de di-hidropirrolo[1,2-c]imidazolil aldosterona sintase ou aromatase BR112014017260A8 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201261587280P 2012-01-17 2012-01-17
PCT/US2013/021521 WO2013109514A1 (en) 2012-01-17 2013-01-15 New forms and salts of a dihydropyrrolo[1,2-c]imidazolyl aldosterone synthase or aromatase inhibitor

Publications (2)

Publication Number Publication Date
BR112014017260A2 true BR112014017260A2 (pt) 2017-06-13
BR112014017260A8 BR112014017260A8 (pt) 2017-07-04

Family

ID=47604250

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112014017260A BR112014017260A8 (pt) 2012-01-17 2013-01-15 formas e sais de um inibidor de di-hidropirrolo[1,2-c]imidazolil aldosterona sintase ou aromatase

Country Status (41)

Country Link
US (2) US9334276B2 (pt)
EP (1) EP2804863B1 (pt)
JP (1) JP5749410B2 (pt)
KR (2) KR20140093726A (pt)
CN (1) CN104039793B (pt)
AP (1) AP2014007762A0 (pt)
AR (1) AR089728A1 (pt)
AU (1) AU2013209952B2 (pt)
BR (1) BR112014017260A8 (pt)
CA (1) CA2863339C (pt)
CL (1) CL2014001863A1 (pt)
CO (1) CO7000775A2 (pt)
CR (1) CR20140345A (pt)
CU (1) CU20140086A7 (pt)
CY (1) CY1117914T1 (pt)
DK (1) DK2804863T3 (pt)
EA (1) EA026232B1 (pt)
ES (1) ES2564143T3 (pt)
GT (1) GT201400155A (pt)
HK (1) HK1198536A1 (pt)
HR (1) HRP20160178T1 (pt)
HU (1) HUE026984T2 (pt)
IL (1) IL233541B (pt)
IN (1) IN2014DN06781A (pt)
JO (1) JO3137B1 (pt)
MA (1) MA35858B1 (pt)
MX (1) MX2014008686A (pt)
NZ (1) NZ626277A (pt)
PE (1) PE20142358A1 (pt)
PH (1) PH12014501638A1 (pt)
PL (1) PL2804863T3 (pt)
RS (1) RS54589B1 (pt)
SG (1) SG11201404061YA (pt)
SI (1) SI2804863T1 (pt)
SM (1) SMT201600083B (pt)
TN (1) TN2014000256A1 (pt)
TW (1) TWI609869B (pt)
UA (1) UA114803C2 (pt)
UY (1) UY34576A (pt)
WO (1) WO2013109514A1 (pt)
ZA (1) ZA201404314B (pt)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5602250B2 (ja) * 2010-01-14 2014-10-08 ノバルティス アーゲー 副腎ホルモン修飾剤の使用
EP2815749A1 (en) 2013-06-20 2014-12-24 IP Gesellschaft für Management mbH Solid form of 4-amino-2-(2,6-dioxopiperidine-3-yl)isoindoline-1,3-dione having specified X-ray diffraction pattern
EA201991359A1 (ru) * 2014-07-07 2020-03-13 Новартис Аг Фармацевтические лекарственные формы
RS61908B1 (sr) * 2015-01-29 2021-06-30 Recordati Ag Postupak za proizvodnju kondenzovanih imidazolo derivata
US20160287565A1 (en) * 2015-04-06 2016-10-06 Millendo Therapeutics, Inc. Combination therapy for treating disorders associated with excess cortisol production
WO2018078049A1 (en) * 2016-10-27 2018-05-03 Damian Pharma Ag Aldosterone synthase inhibitor
KR102506380B1 (ko) 2016-10-27 2023-03-03 다미안 파르마 에이쥐 알도스테론 합성효소 저해제

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1315449A (en) * 1918-11-15 1919-09-09 Frank B Yingling Shaper-feed.
US4617307A (en) * 1984-06-20 1986-10-14 Ciba-Geigy Corporation Substituted imidazo[1,5-A]pyridine derivatives as aromatase inhibitors
US5066656A (en) 1989-11-01 1991-11-19 Janssen Pharmaceutica N.V. Pharmacologically active (6,7-dihydro-5H-pyrrolo[1,2-c]imidazol-5-yl)- and (5,6,7,8-tetrahydroimidazo[1,5-a]pyridin-5-yl) substituted 1H-benzotriazole derivatives
MTP1076B (en) * 1990-01-12 1991-09-30 Ciba Geigy Ag Hemihydrate
DK0625155T3 (da) 1992-01-27 2001-11-12 Janssen Pharmaceutica Nv Pyrroloimidazolyl- og imidazopyridinyl-substituerede 1H-benzimidazolderivater som aromataseinhibitorer
ATE398124T1 (de) 2002-11-18 2008-07-15 Novartis Pharma Gmbh Imidazoä1,5üa pyridin-derivate und methoden zur behandlung von krankheiten in verbindung mit aldosteron
GT200600381A (es) * 2005-08-25 2007-03-28 Compuestos organicos
EP2094669A2 (en) 2006-12-18 2009-09-02 Novartis AG 1-substituted imidazole derivatives and their use as aldosterone synthase inhibitors
EP2507234B1 (en) 2009-11-30 2014-03-12 Novartis AG Imidazole derivatives as aldosterone synthase inhibitors
JP5602250B2 (ja) * 2010-01-14 2014-10-08 ノバルティス アーゲー 副腎ホルモン修飾剤の使用

Also Published As

Publication number Publication date
SI2804863T1 (sl) 2016-05-31
TWI609869B (zh) 2018-01-01
HK1198536A1 (en) 2015-05-15
PL2804863T3 (pl) 2016-06-30
CO7000775A2 (es) 2014-07-21
PE20142358A1 (es) 2015-01-30
CA2863339C (en) 2021-03-23
CY1117914T1 (el) 2017-05-17
ES2564143T3 (es) 2016-03-18
EP2804863B1 (en) 2015-12-02
GT201400155A (es) 2017-09-28
DK2804863T3 (en) 2016-03-07
AP2014007762A0 (en) 2014-07-31
MX2014008686A (es) 2014-08-27
ZA201404314B (en) 2015-08-26
EA026232B1 (ru) 2017-03-31
SG11201404061YA (en) 2014-08-28
AU2013209952B2 (en) 2016-09-01
AR089728A1 (es) 2014-09-10
UA114803C2 (uk) 2017-08-10
HRP20160178T1 (hr) 2016-03-25
HUE026984T2 (en) 2016-08-29
SMT201600083B (it) 2016-04-29
JP5749410B2 (ja) 2015-07-15
IL233541B (en) 2018-12-31
IL233541A0 (en) 2014-08-31
ES2564143T8 (es) 2020-11-18
AU2013209952A1 (en) 2014-07-24
NZ626277A (en) 2015-10-30
RS54589B1 (en) 2016-08-31
TW201335161A (zh) 2013-09-01
BR112014017260A8 (pt) 2017-07-04
EA201491374A1 (ru) 2014-12-30
CA2863339A1 (en) 2013-07-25
CN104039793A (zh) 2014-09-10
TN2014000256A1 (en) 2015-09-30
CU20140086A7 (es) 2014-12-26
PH12014501638B1 (en) 2014-10-13
KR20140093726A (ko) 2014-07-28
CN104039793B (zh) 2017-05-10
UY34576A (es) 2013-09-02
CR20140345A (es) 2014-09-09
WO2013109514A1 (en) 2013-07-25
IN2014DN06781A (pt) 2015-05-22
MA35858B1 (fr) 2014-12-01
JO3137B1 (ar) 2017-09-20
CL2014001863A1 (es) 2014-11-07
KR20140141687A (ko) 2014-12-10
PH12014501638A1 (en) 2014-10-13
US20140364470A1 (en) 2014-12-11
EP2804863A1 (en) 2014-11-26
US20160176883A1 (en) 2016-06-23
US9334276B2 (en) 2016-05-10
JP2015503627A (ja) 2015-02-02

Similar Documents

Publication Publication Date Title
BR112014017260A2 (pt) formas e sais de um inibidor de di-hidropirrolo[1,2-c]imidazolil aldosterona sintase ou aromatase
PH12019502269A1 (en) Quinazoline derivatives for the treatment of viral infections and further diseases
RS61319B1 (sr) Pirazolo[1,5-a]pirimidini korisni kao inhibitori atr kinaze za lečenje kancera
IN2014DN07384A (pt)
TN2014000298A1 (en) Substituted annulated pyrimidines and triazines, and use thereof
EA201590663A1 (ru) ПРОИЗВОДНЫЕ ПИРРОЛО[3,2-d]ПИРИМИДИНА ДЛЯ ЛЕЧЕНИЯ ВИРУСНЫХ ИНФЕКЦИЙ И ДРУГИХ ЗАБОЛЕВАНИЙ
SG11201400616YA (en) Substituted benzylindazoles for use as bub1 kinase inhibitors in the treatment of hyperproliferative diseases.
WO2014096965A3 (en) Novel heterocyclic compounds as bromodomain inhibitors
WO2014145159A3 (en) Charge-engineered antibodies or compositions of penetration-enhanced targeting proteins and methods of use
WO2013052943A3 (en) Small molecule inhibitors of mcl-1 and uses thereof
HK1213542A1 (zh) 用於治療過度增殖性疾病的取代的吲唑-吡咯並嘧啶
WO2012154695A3 (en) Treatment of polycystic disease
HK1212340A1 (en) Substituted indazol pyrrolopyrimidines useful in the treatment of hyperfoliferative disorders
BR112012019302A2 (pt) imidazo[1,2-b][1,2,4]triazinas como inibidores de c-met
MX2013011421A (es) Derivados de pirazolo-pirimidina.
MX340536B (es) Terapia direccionada al receptor del factor de crecimiento epidermico (egfr).
UA111520C2 (uk) [1,2,4]триазолопіридини і їх застосування як інгібіторів фосфодіестерази
TH152473A (th) รูปแบบใหม่และเกลือของไดไฮโดรไพร์โรโล[1,2-c] อิมิดาโซลิลที่เป็นสารยับยั้งอัลโดสเตอโรนซินเธสหรืออะโรมาเตส

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B06T Formal requirements before examination [chapter 6.20 patent gazette]
B11E Dismissal acc. art. 34 of ipl - requirements for examination incomplete
B11T Dismissal of application maintained [chapter 11.20 patent gazette]
B350 Update of information on the portal [chapter 15.35 patent gazette]